{
 "generic_name": "Lasmiditan Succinate Tablet",
 "slug": "lasmiditan-succinate-tablet",
 "brand_names": [
  "Reyvow"
 ],
 "fda_status": [
  "To Be Discontinued"
 ],
 "last_fda_update": "11/03/2025",
 "first_posted": "11/03/2025",
 "synced_at": "2026-10-01T04:04:04.751Z",
 "presentations": [
  {
   "company": "Eli Lilly and Co.",
   "package_ndc": "0002-4312-62",
   "presentation": "Reyvow, Tablet, 50 mg (NDC 0002-4312-62)",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026."
  },
  {
   "company": "Eli Lilly and Co.",
   "package_ndc": "0002-4312-61",
   "presentation": "Reyvow, Tablet, 50 mg (NDC 0002-4312-61)",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026."
  },
  {
   "company": "Eli Lilly and Co.",
   "package_ndc": "0002-4312-08",
   "presentation": "Reyvow, Tablet, 50 mg (NDC 0002-4312-08)",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026."
  },
  {
   "company": "Eli Lilly and Co.",
   "package_ndc": "0002-4491-08",
   "presentation": "Reyvow, Tablet, 100 mg (NDC 0002-4491-08)",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026."
  },
  {
   "company": "Eli Lilly and Co.",
   "package_ndc": "0002-4491-61",
   "presentation": "Reyvow, Tablet, 100 mg (NDC 0002-4491-61)",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026."
  },
  {
   "company": "Eli Lilly and Co.",
   "package_ndc": "0002-4491-62",
   "presentation": "Reyvow, Tablet, 100 mg (NDC 0002-4491-62)",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026."
  }
 ],
 "changes": []
}